Balchem Corp (BCPC) 55.72 $BCPC Balchem Appoints

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Balchem Corp (BCPC) 55.72 $BCPC

Balchem Appoints Theodore Harris President and Chief Executive Officer
GlobeNewswire - Wed Apr 22, 8:00AM CDT
Balchem Corporation (Nasdaq:BCPC) today announced that its Board of Directors has appointed Theodore (Ted) L. Harris as President and Chief Executive Officer, succeeding Balchem's President and Chief Executive Officer, Dino A. Rossi, who will remain Chairman of the Board. Harris will also join the Balchem Board of Directors. These changes will become effective April 28, 2015.
ASH: 127.06 (+0.15), BCPC: 55.72 (-1.00)

My Top Chemicals Stocks For 2015
Stan Stafford - at Seeking Alpha - Wed Mar 04, 6:38AM CST

IFF: 115.99 (-0.83), GRA: 97.10 (+0.03), EMN: 76.08 (+1.55), IOSP: 44.95 (+0.29), CYT: 56.98 (+0.34), MTX: 68.84 (-1.34), BCPC: 55.72 (-1.00), HUN: 22.43 (+0.18), LYB: 97.11 (+0.56), CE: 65.75 (-0.19), SHLM: 45.77 (-0.11), AGU: 104.55 (-0.59), RPM: 48.53 (-0.20), SHW: 281.64 (-0.78), PX: 121.26 (+0.03), FTK: 15.56 (+0.10), DOW: 50.02 (+0.37), PPG: 226.40 (-0.65), MEOH: 55.06 (-0.62), CBT: 45.87 (+0.75), ECL: 116.05 (+0.17)

Balchem Corp's (BCPC) CEO Bill Backus on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 24, 8:30PM CST

BCPC: 55.72 (-1.00)

Blachem posts 4Q profit
Automated Insights - Tue Feb 24, 10:58AM CST
NEW HAMPTON, N.Y. (AP) _ Balchem Corp. (BCPC) on Tuesday reported fourth-quarter net income of $19 million.
BCPC: 55.72 (-1.00)

Balchem beats by $0.08, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 8:33AM CST

BCPC: 55.72 (-1.00)

Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 24, 2015
GlobeNewswire - Fri Feb 13, 3:15PM CST
Balchem Corporation (Nasdaq:BCPC) today announced that a conference call will be held on Tuesday, February 24, 2015, at 11:00 AM Eastern Time (ET) to review fourth quarter 2014 results. Dino A. Rossi, Chairman, President and CEO, and Bill Backus, Chief Financial Officer, will host the call.
BCPC: 55.72 (-1.00)

Shares of BCPC Down 9.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Feb 12, 4:53PM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.22. In approximately 1 month, Balchem has returned 9.31% as of today's recent price of $57.34.
BCPC: 55.72 (-1.00)

13.2% Return Seen to Date on SmarTrend Balchem Call (BCPC)
Comtex SmarTrend(R) - Thu Feb 05, 11:15AM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.23. In approximately 1 month, Balchem has returned 13.17% as of today's recent price of $54.90.
BCPC: 55.72 (-1.00)

Shares of BCPC Down 16.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 29, 10:00AM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.23. In approximately 3 weeks, Balchem has returned 16.09% as of today's recent price of $53.05.
BCPC: 55.72 (-1.00)

Downtrend Call Working As Balchem Stock Falls 19.6% (BCPC)
Comtex SmarTrend(R) - Thu Jan 22, 10:05AM CST
SmarTrend identified a Downtrend for Balchem (NASDAQ:BCPC) on January 5th, 2015 at $63.23. In approximately 2 weeks, Balchem has returned 19.64% as of today's recent price of $50.81.
BCPC: 55.72 (-1.00)

Balchem slides after new short report
Seeking Alpha - at Seeking Alpha - Tue Jan 20, 1:06PM CST

BCPC: 55.72 (-1.00)

Uptrend Call Working As Balchem Stock Rises 17.2% (BCPC)
Comtex SmarTrend(R) - Fri Jan 02, 9:30AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 3 months, Balchem has returned 17.24% as of today's recent price of $66.85.
BCPC: 55.72 (-1.00)

Balchem: Staying Bullish As The Company Hikes Its Dividend
Heather Ingrassia - at Seeking Alpha - Wed Dec 31, 10:50AM CST

BCPC: 55.72 (-1.00)

Balchem declares $0.30 dividend
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 2:06PM CST

BCPC: 55.72 (-1.00)

Balchem Corporation Announces Dividend
GlobeNewswire - Fri Dec 19, 2:00PM CST
Balchem Corporation (Nasdaq:BCPC) today announced that its Board of Directors has declared a dividend on its shares of common stock equal to $0.30 per share, payable on January 27, 2015 to holders of record on December 29, 2014. This dividend reflects a 15% increase over the prior year cash dividend.
BCPC: 55.72 (-1.00)

Balchem Has Returned 13.7% Since SmarTrend Recommendation (BCPC)
Comtex SmarTrend(R) - Wed Dec 17, 11:15AM CST
SmarTrend identified an Uptrend for Balchem (NASDAQ:BCPC) on October 16th, 2014 at $57.02. In approximately 2 months, Balchem has returned 13.68% as of today's recent price of $64.82.
BCPC: 55.72 (-1.00)

Stocks Mixed In Volatile Session; Boeing Boosts Dow
at Investor's Business Daily - Tue Dec 16, 2:04PM CST
Stocks wavered and were mixed heading into the final hour Tuesday. The Dow clung to a 0.2% gain, while the S&P 500 added a fraction and the Nasdaq fell 0.4%. Volume was tracking mildly higher across the board. The Russell 2000 outperformed in the...
AKRX: 53.70 (-1.69), BA: 151.19 (-2.14), BCPC: 55.72 (-1.00), MMS: 67.34 (+0.43)

United States Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry Analytics 2014-2021 - Market to reach $21.2 billion by 2021
M2 - Mon Dec 15, 8:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7xlml/vitamins) has announced the addition of Plunkett Research Ltd's new report "Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Aceto Corporation - Balchem Corp - Cambrex Corp - Mannatech Inc - Mead Johnson Nutrition Company - NBTY Inc - Schiff Nutrition International Inc - Sigma-Aldrich Corp - Synutra International, Inc. - USANA Health Sciences Inc For more information visit http://www.researchandmarkets.com/research/b7xlml/vitamins Source: Plunkett Research Ltd
ACET: 20.17 (-0.25), MJN: 98.92 (-1.00), CBM: 42.07 (-0.65), SIAL: 138.92 (+0.17), USNA: 123.36 (+2.82), SYUT: 7.61 (-0.01), MTEX: 20.83 (+0.14), BCPC: 55.72 (-1.00)

Dividend Challengers: 24 Increases Expected By February 28
David Fish - at Seeking Alpha - Sat Dec 13, 2:17PM CST

HOG: 56.23 (+0.51), LAZ: 56.56 (-0.08), AIV: 38.63 (+0.70), CNP: 20.83 (+0.17), AIT: 41.99 (+0.14), UPS: 98.14 (+0.53), SLB: 92.16 (+0.87), PRI: 47.88 (-0.67), VLO: 59.35 (+1.02), MAT: 28.36 (+1.14), AJG: 47.71 (+0.05), MMLP: 36.75 (+0.61), HME: 68.48 (+0.68), MWE: 66.82 (+0.13), RES: 15.39 (+0.65), INGR: 77.75 (-0.03), PFE: 34.93 (+0.04), ALL: 70.88 (+0.06), CLB: 114.00 (-0.73), RAS: 6.76 (+0.01), MCO: 107.23 (+1.24), FLIR: 30.45 (+0.23), SMP: 41.82 (+0.04), CPA: 108.07 (+0.88), ARCP: 9.27 (+0.08), HEI: 59.00 (-0.34), EWBC: 41.97 (-0.02), MKTX: 88.66 (-1.35), SNI: 69.88 (+1.13), BCPC: 55.72 (-1.00), FCF: 9.12 (unch), GMT: 59.92 (+0.42), ALE: 50.65 (-0.22), TAL: 41.62 (-0.19), EMCF: 25.10 (-0.86), WDR: 49.79 (+0.18), TLLP: 56.71 (+0.51), EPR: 59.11 (-0.21), EME: 46.28 (-0.11), PCBK: 12.99 (+0.06), X: 25.78 (-0.07), CMS: 35.07 (+0.15), LGCY: 13.26 (-0.48), CUBE: 23.71 (+0.27), AMGN: 169.10 (+0.64), EFX: 94.19 (-0.29), ATK: 140.03 (+0.78), FINL: 25.44 (+0.56), LEA: 116.57 (+0.28), TESS: 26.13 (+0.40), LB: 91.13 (-1.10), HPY: 51.65 (+0.62), DNB: 132.31 (+0.17), BIP: 44.65 (-0.04), TOO: 23.26 (+0.07), FIBK: 28.41 (+0.28), CNA: 40.46 (-0.25), MOFG: 29.35 (-0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

IMCD Expands Reach in Latin America with Blumos Acquisition

Updated Category News Views 88

IMCD Expands Reach in Latin America with Blumos Acquisition IMCD N.V. is making significant strides in the life science markets across Latin America through its recent acquisition of the Blumos Group. This move showcases IMCD's commitment to growing its footprint in the region, enhancing its distribution of specialty chemicals and ingredients. About Blumos Group Founded...

Continue Reading
Insights on the Recent Decline of SolarEdge Technologies (SEDG)

Updated Category News Views 129

Understanding the Decline of SolarEdge Technologies SolarEdge Technologies Inc (NASDAQ: SEDG) recently faced a notable decline in its stock price, falling by 5.47% to $17.96. This drop is part of a broader downward trend affecting clean energy stocks, triggered by concerns surrounding the pricing strategies and performance expectations of major players in the solar energy...

Continue Reading
FCP Secures $16.7M for Multifamily Project in Lake Nona

Updated Category News Views 191

FCP Closes $16.7 Million for Royal Palm at Nona Development FCP has announced a significant milestone by closing a $16.7 million preferred equity investment aimed at financing the Royal Palm at Nona project. This 320-unit, Class A multifamily development is set to rise in a rapidly growing submarket. The development is spearheaded by Royal Palm Companies, a reputable firm...

Continue Reading
TeamLinkt Receives Growth Investment to Expand AI Sports Platform

Updated Category News Views 318

TeamLinkt Gains Momentum with Strategic Investment TeamLinkt, a groundbreaking sports management platform, proudly announces a significant minority growth investment from Growth Street Partners. This investment marks an exciting chapter for TeamLinkt as it aims to enhance its technology and expand support services for sports leagues, clubs, and associations....

Continue Reading
Glucose Health Validates Fiber's Importance for Public Well-Being

Updated Category News Views 102

Glucose Health, Inc. Shines a Light on Dietary Fiber's Importance In an important recognition, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA) have identified dietary fiber as a nutrient of public health concern. This announcement holds significant weight for Glucose Health, Inc. (OTC: GLUC), a leader in diabetic...

Continue Reading